---
category: news
title: "Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty"
excerpt: "Progenics Pharmaceuticals, Inc., a Lantheus company, licensed methylnaltrexone (MNTX) along with products containing MNTX including the Tablet and Subcutaneous injection RELISTOR® products to Salix Pharmaceuticals, Inc., a Bausch Health company in 2011."
publishedDateTime: 2023-08-03T11:28:00Z
originalUrl: "https://technews.tmcnet.com/news/2023/08/03/9858834.htm"
webUrl: "https://technews.tmcnet.com/news/2023/08/03/9858834.htm"
type: article
quality: 15
heat: 15
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "vRV3tHoXjyTZQvS7xnZM9Vr+fgAeGB1eTDh9j3hUA57+wPruRCn64cr7z0BpJHNvEeHvRFl6ZYHfJoSfo0w0DKxm6AWlpmj26Vgsa3dmAEybxK78D00l3wVDfzN7iqJeGbB/quFRKUC8kM4Qg9FU2GDi4Dz2Tck/KLI1fMrHfxxOH2rBGfw1kfB++uUDXMPWfcXmK8+jygrw7azxN1mZEFDpP+KpovdcWnJJgsxYourKh7RrNqSIx3BjqcoD/r8T0HDBY5VDJxGtwlUphRVPdLf62SeWBkvEhsaDNlTg8bFdjlhQtkBHNmeRP90sEK/6CHg0AHqANa6NEAcfes1F+9tMXOyWppZ8triRzsc9M1M=;Ephd+jf/xKz7H6BTUAir9Q=="
---

